A detailed history of Wolverine Trading, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 4,339 shares of CTLT stock, worth $275,439. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,339
Previous 3,800 14.18%
Holding current value
$275,439
Previous $213,000 23.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $243,678 - $264,505
4,339 New
4,339 $262,000
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $254,891 - $358,261
5,989 New
5,989 $338,000
Q2 2023

Aug 23, 2023

BUY
$31.86 - $67.26 $648,828 - $1.37 Million
20,365 New
20,365 $883,000
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $2.17 Million - $2.53 Million
-18,175 Reduced 83.97%
3,470 $446,000
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $4,257 - $5,551
-39 Reduced 0.18%
21,645 $2.91 Million
Q2 2021

Aug 06, 2021

BUY
$100.34 - $115.69 $833,524 - $961,036
8,307 Added 62.1%
21,684 $2.37 Million
Q1 2021

May 14, 2021

BUY
$101.51 - $125.27 $533,029 - $657,792
5,251 Added 64.62%
13,377 $1.39 Million
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $486,166 - $596,442
-5,661 Reduced 41.06%
8,126 $839,000
Q3 2020

Nov 13, 2020

BUY
$72.74 - $92.5 $604,687 - $768,952
8,313 Added 151.86%
13,787 $1.18 Million
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $163,344 - $240,418
5,474 New
5,474 $222,000
Q4 2018

Feb 14, 2019

SELL
$29.95 - $46.34 $225,194 - $348,430
-7,519 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$40.12 - $45.55 $70,530 - $80,076
-1,758 Reduced 18.95%
7,519 $342,000
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $89,559 - $103,377
2,403 Added 34.96%
9,277 $381,000
Q3 2017

Nov 15, 2017

BUY
$33.75 - $41.67 $231,997 - $286,439
6,874
6,874 $274,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.